Serial profiling of circulating tumor DNA for optimization of anti‐VEGF chemotherapy in metastatic colorectal cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|142|7|1418-1426

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.7, 2018-04, pp. : 1418-1426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategic Options on Behalf of Patients with Metastatic Colorectal Cancer: Mass Tumor Murder versus Serial Tumor Killing

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 291-292

Karger

Access to resources Recommend Favorite

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1397-1405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 93, Iss. 3, 2017-05 ,pp. : 191-196

Karger

Access to resources Recommend Favorite

Chemotherapy-Induced Carcinoembryonic Antigen Surge in Patients with Metastatic Colorectal Cancer

By  

Oncology, Vol. 70, Iss. 1, 2006-03 ,pp. : 49-53

Karger

Access to resources Recommend Favorite

Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody

By  

Oncology, Vol. 92, Iss. 4, 2017-02 ,pp. : 205-212

Karger

Access to resources Recommend Favorite